Action 4737 BIONIME CORPORATION
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Bionime Corporation

Actions

4737

TW0004737002

Cours en clôture Taiwan S.E.
Autres places de cotation
 00:00:00 07/05/2024 		Varia. 5j. Varia. 1 janv.
72,3 TWD +4,03% Graphique intraday de Bionime Corporation +5,86% -3,34%
15/03 Bionime Corporation publie ses résultats pour l'exercice clos le 31 décembre 2023 CI
2023 Bionime Corporation présente ses résultats pour le troisième trimestre et les neuf mois clos le 30 septembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Bionime Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
Bionime Corporation Announces Dividend for the Year Ended December 31, 2023
Bionime Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Bionime Corporation Announces TFDA Approval for iFree Continuous Glucose Monitoring System Second-Class Medical Device License
Bionime Corporation Announces Resignation of Marvin Wu as Globle Sales Division Officer
Bionime Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Bionime Corporation Announces Appointment of Aling Lai as New Member to the Remuneration Committee
Bionime Corporation Appoints Aling Lai as Additional Member of Audit Committee
Bionime Corporation Approves Cash Dividends, Payable on August 18, 2023
Bionime Corporation Announces Election of Aling Lai as an Additional Independent Director
Bionime Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
Bionime Corporation Revises Cash Dividend for 2022
Bionime Corporation Appoints Chen Hui-Zhen as Corporate Governance Officer
Bionime Corporation Announces Cash Dividend for 2022
Bionime Corporation Announces Resignation of Tai,Tsung-Kai as Institutional Director, Effective April 30, 2023
Bionime Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Bionime Corporation Approves the Factory Area to Expand Building the Clean Room to Accommodate Production Equipment and Increase Production Capacity
Bionime Announces the Introduction of Its Revolutionary iFree CGM for Diabetes Management Coming Soon
Bionime Corporation to Launch the Rightest iFree CGM, Proposed to Offer Precise and Accurate Blood Glucose Measurement and Monitoring
Bionime RIGHTEST iFree CGM System - An Innovative Approach to Keep Track of Every One Health
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 4737
  4. Actualités Bionime Corporation
  5. Autres langues